Logo for Processa Pharmaceuticals Inc

Processa Pharmaceuticals Investor Relations Material

Latest events

Logo for Processa Pharmaceuticals Inc

Q4 2022

Processa Pharmaceuticals
Logo for Processa Pharmaceuticals

Q3 2024

30 Oct, 2024
Logo for Processa Pharmaceuticals

Q2 2024

28 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Processa Pharmaceuticals Inc

Access all reports
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs. The company is engaged in the research and development of drug candidates aimed at addressing serious conditions across multiple therapeutic areas, including oncology and infectious diseases. Processa Pharmaceuticals' approach involves advancing its drug candidates through clinical trials to provide safer and more effective therapies. Its pipeline targets conditions where current treatment options may be limited or inadequate, aiming to improve patient outcomes and quality of life. The company is headquartered in Hanover, Maryland, and its shares are listed on the NASDAQ.